Clinical data | |
---|---|
Other names | KUR-1246; MN-221 |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C24H32N2O5 |
Molar mass | 428.529 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Bedoradrine (INNTooltip International Nonproprietary Name; developmental code names KUR-1246, MN-221) is a sympathomimetic and bronchodilator medication that was developed for the treatment of preterm labor, asthma, and chronic obstructive pulmonary disease (COPD) but was never marketed. It acts as an ultra-selective long-acting β2-adrenergic receptor agonist. The drug was intended for intravenous administration.
See also
References
- ^ Antoniu S (August 2014). "Bedoradrine for treating asthma and chronic obstructive pulmonary disease". Expert Opin Investig Drugs. 23 (8): 1149–1156. doi:10.1517/13543784.2014.928284. PMID 24938936.
- ^ Cazzola M, Calzetta L, Matera MG (May 2011). "β(2) -adrenoceptor agonists: current and future direction". Br J Pharmacol. 163 (1): 4–17. doi:10.1111/j.1476-5381.2011.01216.x. PMC 3085864. PMID 21232045.
- "Bedoradrine: Uses, Interactions, Mechanism of Action". DrugBank Online. 18 November 2007. Retrieved 1 September 2024.
Tocolytics/labor repressants (G02CA) | |
---|---|
β2 adrenoreceptor agonists | |
Oxytocin antagonists | |
NSAIDs | |
Calcium channel blockers | |
Myosin inhibitors |
Phenethylamines | |
---|---|
Phenethylamines |
|
Amphetamines |
|
Phentermines |
|
Cathinones |
|
Phenylisobutylamines | |
Phenylalkylpyrrolidines | |
Catecholamines (and close relatives) |
|
Miscellaneous |
|
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |